Medicine & Life Sciences
Angiogenesis Inhibitors
21%
Bevacizumab
9%
Breast Neoplasms
11%
Colorectal Neoplasms
7%
Docetaxel
9%
Drug Therapy
5%
Fibroblast Growth Factors
10%
Growth
4%
Hepatocellular Carcinoma
7%
Medullary Thyroid cancer
11%
Monoclonal Antibodies
6%
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
14%
Neoplasm Metastasis
5%
Neoplasms
20%
nintedanib
100%
Non-Small Cell Lung Carcinoma
16%
Ovarian Neoplasms
8%
pazopanib
13%
Platelet-Derived Growth Factor
10%
Prostatic Neoplasms
7%
Renal Cell Carcinoma
34%
Safety
5%
Sorafenib
11%
Stomach Neoplasms
7%
Sunitinib
11%
Therapeutics
10%
Vascular Endothelial Growth Factor A
23%